公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2008 | APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese | KUO-LIONG CHIEN ; WOEI-HORNG FANG ; Wen H.-C.; Lin H.-P.; Lin Y.-L.; SHU-WHA LIN ; Wu J.-H.; JAU-TSUEN KAO | Clinica Chimica Acta | 35 | 31 | |
1996 | Apolipoprotein B 3′ hypervariable repeat genotype: Association with plasma lipid concentration, coronary artery disease, and other restriction fragment polymorphisms | Wu J.H.; Chern M.-S.; Lo S.-K.; Wen M.-S.; JAU-TSUEN KAO | Clinical Chemistry | 16 | 15 | |
2003 | Apolipoprotein ε2/3 genotype and type III hyperlipoproteinemia among Taiwanese | Lin H.-P.; JAU-TSUEN KAO | Clinica Chimica Acta | 8 | 6 | |
2006 | Association between the apolipoprotein E genotypes and breast cancer patients in Taiwanese | Chang S.-J.; Hou M.-F.; Tsai S.-M.; JAU-TSUEN KAO ; Wu S.-H.; Hou L.A.; Tsai L.-Y. | Breast Cancer Research and Treatment | 12 | 13 | |
2004 | Association of apolipoprotein E genotypes with serum lipid profiles in a healthy population of Taiwan | Lin S.-K.; JAU-TSUEN KAO ; Tsai S.-M.; Tsai L.-Y.; Lin M.-N.; Lai C.-J.; Zhong W.-L. | Annals of Clinical and Laboratory Science | 20 | 18 | |
1998 | Association of apolipoprotein E polymorphism with lipoprotein glomerulopathy. Report of 2 cases with a new genotype and comparison of the relative frequencies of apolipoprotein E isoforms in lipoprotein glomerulopathy and in the general population | JAU-TSUEN KAO | Nephron | 15 | 14 | |
2009 | Association of single-nucleotide polymorphism 3 and c.553G>T of APOA5 with hypertriglyceridemia after treatment with highly active antiretroviral therapy containing protease inhibitors in HIV-infected individuals in Taiwan | SUI-YUAN CHANG ; Ko W.-S.; JAU-TSUEN KAO ; Chang L.-Y.; HSIN-YUN SUN ; Chen M.-Y.; SZU-MIN HSIEH ; WANG-HUEI SHENG ; Chang S.-F.; Liu W.-C.; Wu C.-H.; Hsu H.-J.; CHUAN-LIANG KAO ; Lee C.-N.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Clinical Infectious Diseases | 18 | 15 | |
2011 | Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B | Kao C.-Y.; Lin C.-N.; YUNG-LI YANG ; Hamaguchi N.; Yang S.-J.; MING-CHING SHEN ; JAU-TSUEN KAO ; SHU-WHA LIN | Thrombosis and Haemostasis | 1 | 1 | |
2002 | Characterization of apolipoprotein E genetic variations in Taiwanese: Association with coronary heart disease and plasma lipid levels | Wu J.H.; Lo S.-K.; Wen M.-S.; JAU-TSUEN KAO | Human Biology | 21 | 17 | |
2009 | Common sequence variant in lipoprotein lipase gene conferring triglyceride response to fibrate treatment | KUO-LIONG CHIEN ; Lin Y.-L.; Wen H.-C.; Lin H.-P.; Yen C.-T.; SHU-WHA LIN ; JAU-TSUEN KAO | Pharmacogenomics | 6 | 5 | |
2006 | Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP | Chien T.-I.; Chen H.-h.; JAU-TSUEN KAO | Clinica Chimica Acta | 34 | 27 | |
2001 | Comparison of Abbott AxSYM, Behring Opus Plus, DPC Immulite and Ortho-Clinical Diagnostics Vitros ECi for measurement of cardiac troponin I | JAU-TSUEN KAO ; Wong I.-L.; Lee J.-Y.; Chen R.-C. | Annals of Clinical Biochemistry | 14 | 11 | |
1996 | Comparison of isoproterenol with BRL37344 in activation of β3-adrenoceptors to inhibit the uptake of [14C]deoxy-D-glucose and translocation of glucose transporter (GLUT4) to membrane fraction in rat adipocytes | Chang C.J.; JAU-TSUEN KAO ; Lee T.-L.; Lai C.-W.; Cheng J.-T. | Journal of the Autonomic Nervous System | 19 | 18 | |
2010 | Comparison of the Analytical Performance for Measurement of Cardiac Troponin Ⅰ | Tzu-I Chien; JAU-TSUEN KAO ; Po-Chang Lin; Hsiang-Her Lai; Cheng-An Hsu; Yi-Kuang Chuang; Miao-Ju Chien; Han-Peng Hsieh; Chun-Erh Wang | Journal of Biomedical & Laboratory Sciences | | 0 | |
2007 | Comparison of three automated urinalysis systems-Bayer Clinitek Atlas, Roche Urisys 2400 and Arkray Aution Max for testing urine chemistry and detection of bacteriuria | Chien T.-I.; JIN-YING LU ; JAU-TSUEN KAO ; Lee T.-F.; Ho S.-Y.; Chang C.-Y.; Liu C.-W.; Lee C.-H.; Yan S.-N.; Yang J.-Y.; Lin P.-C.; Wang M.-J. | Clinica Chimica Acta | 17 | 14 | |
1993 | Coronary artery disease risk predicted by plasma concentrations of high-density lipoprotein cholesterol, apolipoprotein AI, apolipoprotein B, and lipoprotein(a) in a general Chinese population | Wu, June Hsieh; JAU-TSUEN KAO ; Wen, Ming-Shien; Wu, Delon | Clinical chemistry | 36 | 31 | |
2011 | Corrigendum to "Endonuclease V-mediated deoxyinosine excision repair in vitro" [DNA Repair 9 (2010) 1073-1079] | Lee C.-C.; YA-CHIEN YANG ; Goodman S.D.; Yu Y.-H.; Lin S.-B.; JAU-TSUEN KAO ; KEH-SUNG TSAI ; WOEI-HORNG FANG | DNA Repair | 0 | 0 | |
2000 | DNA polymorphisms at the apolipoprotein A1-CIII loci in Taiwanese: Correlation of plasma apoCIII with triglyceride level and body mass index | Wu J.H.; JAU-TSUEN KAO ; Wen M.-S.; Lo S.-K. | Journal of the Formosan Medical Association | 20 | 21 | |
1999 | The effectiveness of a quality assurance program for clinical laboratories of the Bureau of Public Health in Taiwan | Hsu W.-S.; JAU-TSUEN KAO ; Ho S.-W. | Tzu Chi Medical Journal | 1 | | |
2003 | Effects of air bubbles and tube transportation on blood oxygen tension in arterial blood gas analysis | JIN-YING LU ; JAU-TSUEN KAO ; Chien T.-I.; Lee T.-F.; KEH-SUNG TSAI | Journal of the Formosan Medical Association | 22 | 17 | |